NO20110884A1 - Tykk furunalekstraktsammensetning for innkapsling - Google Patents
Tykk furunalekstraktsammensetning for innkapsling Download PDFInfo
- Publication number
- NO20110884A1 NO20110884A1 NO20110884A NO20110884A NO20110884A1 NO 20110884 A1 NO20110884 A1 NO 20110884A1 NO 20110884 A NO20110884 A NO 20110884A NO 20110884 A NO20110884 A NO 20110884A NO 20110884 A1 NO20110884 A1 NO 20110884A1
- Authority
- NO
- Norway
- Prior art keywords
- vitamin
- thick
- dcne
- encapsulation
- needle extract
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 9
- 238000005538 encapsulation Methods 0.000 title claims abstract description 7
- 235000008331 Pinus X rigitaeda Nutrition 0.000 title claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 title claims description 3
- 241000018646 Pinus brutia Species 0.000 title claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 26
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 23
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940087168 alpha tocopherol Drugs 0.000 claims abstract description 12
- 229960000984 tocofersolan Drugs 0.000 claims abstract description 12
- 235000004835 α-tocopherol Nutrition 0.000 claims abstract description 12
- 239000002076 α-tocopherol Substances 0.000 claims abstract description 12
- 229960003471 retinol Drugs 0.000 claims abstract description 11
- 235000020944 retinol Nutrition 0.000 claims abstract description 11
- 239000011607 retinol Substances 0.000 claims abstract description 11
- 239000011669 selenium Substances 0.000 claims abstract description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 10
- 229930003231 vitamin Natural products 0.000 claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 claims abstract description 10
- 239000011782 vitamin Substances 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 9
- 239000011712 vitamin K Substances 0.000 claims abstract description 9
- 229930192627 Naphthoquinone Natural products 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- 229930003448 Vitamin K Natural products 0.000 claims abstract description 8
- 150000002791 naphthoquinones Chemical class 0.000 claims abstract description 8
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 150000003721 vitamin K derivatives Chemical class 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 8
- 229940046010 vitamin k Drugs 0.000 claims abstract description 8
- 235000004626 essential fatty acids Nutrition 0.000 claims abstract description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011701 zinc Substances 0.000 claims abstract description 5
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 7
- 239000008158 vegetable oil Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000009206 extralife Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000002775 capsule Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000218631 Coniferophyta Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229930186185 Polyprenol Natural products 0.000 description 2
- 229920001731 Polyprenol Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 210000005095 gastrointestinal system Anatomy 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 150000003254 radicals Chemical group 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001764 biostimulatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009548 growth disturbance Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- -1 monooxyethylene sorbitan Chemical compound 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008212 organismal development Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003096 polyprenols Chemical class 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-08-205A LV13888B (lv) | 2008-12-04 | 2008-12-04 | Skuju biezo ekstraktu saturošs sastāvs iekapsulēšanai |
| PCT/LV2009/000009 WO2010064882A1 (fr) | 2008-12-04 | 2009-10-01 | Composition d’un extrait épais du feuillage de conifères destinée à la mise en capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20110884A1 true NO20110884A1 (no) | 2011-06-20 |
Family
ID=40775140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20110884A NO20110884A1 (no) | 2008-12-04 | 2011-06-20 | Tykk furunalekstraktsammensetning for innkapsling |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110280960A1 (fr) |
| CN (1) | CN102264376A (fr) |
| CA (1) | CA2745579C (fr) |
| FI (1) | FI123675B (fr) |
| LV (1) | LV13888B (fr) |
| NO (1) | NO20110884A1 (fr) |
| PL (1) | PL217762B1 (fr) |
| WO (1) | WO2010064882A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012343263B2 (en) | 2011-11-21 | 2017-10-26 | The University Of British Columbia | Diterpene synthases and method for producing diterpenoids |
| CN109380724A (zh) * | 2018-12-10 | 2019-02-26 | 凃玉英 | 一种无酒精的红酒胶囊及制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1787440C (ru) * | 1990-10-23 | 1993-01-15 | Рижский Медицинский Институт | Вещество, обладающее бактерицидным и репаративным действием |
| RU2137471C1 (ru) * | 1996-05-28 | 1999-09-20 | Акционерное общество открытого типа "Уралбиофарм" | Масляно-поливитаминный препарат |
| RU2143212C1 (ru) * | 1998-07-29 | 1999-12-27 | Общество с ограниченной ответственностью "Фитолон" | Биологически активная добавка |
| US20030224071A1 (en) * | 1999-08-20 | 2003-12-04 | Howard Murad | Pharmaceutical compositions and methods for managing connective tissue ailments |
| EP1527774A1 (fr) * | 2003-11-03 | 2005-05-04 | Basilea Pharmaceutica AG | Formulations nouvelle pour retinoides contenant capsules de gélatine molle |
| US20070148266A1 (en) * | 2003-10-30 | 2007-06-28 | Loders Croklaan B.V. | Pine needle extract |
| RU2275192C2 (ru) * | 2004-05-27 | 2006-04-27 | Закрытое акционерное общество "Алтайвитамины" | Витаминно-минеральный комплекс |
-
2008
- 2008-12-04 US US13/130,860 patent/US20110280960A1/en not_active Abandoned
- 2008-12-04 LV LVP-08-205A patent/LV13888B/lv unknown
-
2009
- 2009-10-01 CN CN2009801480094A patent/CN102264376A/zh active Pending
- 2009-10-01 CA CA2745579A patent/CA2745579C/fr active Active
- 2009-10-01 PL PL394895A patent/PL217762B1/pl unknown
- 2009-10-01 WO PCT/LV2009/000009 patent/WO2010064882A1/fr active Application Filing
-
2011
- 2011-06-20 NO NO20110884A patent/NO20110884A1/no not_active Application Discontinuation
- 2011-07-01 FI FI20115698A patent/FI123675B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL394895A1 (pl) | 2011-09-26 |
| LV13888B (lv) | 2009-06-20 |
| FI123675B (fi) | 2013-09-13 |
| CA2745579A1 (fr) | 2010-06-10 |
| PL217762B1 (pl) | 2014-08-29 |
| LV13888A (lv) | 2009-03-20 |
| CN102264376A (zh) | 2011-11-30 |
| WO2010064882A1 (fr) | 2010-06-10 |
| FI20115698A (fi) | 2011-07-01 |
| US20110280960A1 (en) | 2011-11-17 |
| CA2745579C (fr) | 2018-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI699219B (zh) | 軟膠囊皮膜用組成物 | |
| TWI309984B (en) | Composition for capsule coating, capsule coating, and capsule agent | |
| US20190008907A1 (en) | Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases | |
| CN110522038A (zh) | 复合蓝莓、黑果腺肋花楸和鱼胶原蛋白肽的健康食品 | |
| CN101810550A (zh) | 一种含越橘提取物的化妆品或药妆品混合物 | |
| EP3773466A1 (fr) | Composition topique comprenant de l'huile de foie de morue et destinée au traitement de plaies et de troubles de la peau | |
| NO20110884A1 (no) | Tykk furunalekstraktsammensetning for innkapsling | |
| RU2419446C1 (ru) | Состав экстракта хвои густого для капсулирования | |
| CN102000108A (zh) | 一种妇科药物组合物及外用胶囊与应用 | |
| KR20160041302A (ko) | 하이드로졸을 함유하는 여드름 피부용 화장료 조성물 제조방법 | |
| RU2381810C1 (ru) | Гель-бальзам, обладающий ранозаживляющим действием | |
| KR20150112401A (ko) | 알킨산이 함유된 갈조류 추출물의 제조방법 | |
| CN107006622A (zh) | 一种养生食用油及其制备方法 | |
| WO2014134834A1 (fr) | Composition et aliment la comprenant, et procédé de préparation d'aliment | |
| CN108136210A (zh) | 含有单宁的组合物 | |
| JP3131917U (ja) | ソフトカプセル | |
| KR101612244B1 (ko) | 소금을 이용한 인체 피부용 기능성 제재 | |
| RU2448683C1 (ru) | Мазь на основе грецкого ореха молочно-восковой фазы зрелости и каштана конского | |
| RU2400214C1 (ru) | Средство косметическое для ухода за кожей с заживляющим и регенерирующим действием | |
| CN107281265B (zh) | 一种祛毒提效及抗氧化的亚麻籽制剂及其制备方法 | |
| Zuikina et al. | Research on the composition development and phyto-ointment technology for complex mastopathy therapy | |
| Hossain | Preparation and Characterisation of Alginate-Based Honey-Loaded Topical Formulations | |
| UA151369U (uk) | Спосіб одержання комбінованого лікарського засобу для місцевого застосування в терапії променевих, запальних ушкоджень шкіри | |
| WO2023214953A1 (fr) | Baume de mamelon et formulations cosmétiques contenant de l'huile de graine de sureau encapsulée | |
| RO135808A2 (ro) | Cremă nutritivă şi regeneratoare cu extract lipidic total de rapana (rapana venosa) şi ulei de cânepă |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |